We'll bring consistent premium pharmaceutical products to patients across the UK. Mamedica will serve as the official licence holder and distributor of Cookies’ medical cannabis in the UK, supplied by SOMAÍ Group.
Broadening access to medical cannabis in the UK, the collaboration will ensure that patients can be legally prescribed Cookies’ signature strains – known for our unique terpene profiles and genetics. Cultivated and processed in accordance with EU-GMP (Good Manufacturing Practice) and GACP (Good Agricultural and Collection Practice) standards, these products offer patients a consistent and high-quality medical cannabis option.
Jon Robson, CEO and founder of Mamedica, discusses the significance of this partnership for UK patients: "This partnership with Cookies signals a new era for UK medical cannabis patients. By combining Mamedica’s clinical expertise with Cookies’ world-class genetics and brand heritage, we’re delivering premium cannabis products backed by science, safety, and patient-centred care."
Berner added: "We’re excited to partner with Mamedica to bring Cookies to the UK medical cannabis space. Our goal has always been to make our genetics accessible to patients globally, and the UK is a key part of that mission."